Analytical Validation of Accelerator Mass Spectrometry for Pharmaceutical Development

• Viswanathan CT , BansaiS, BoothBet al. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. Pharm. Res. 10, 1962–1973 (2007).
   Google Scholar
• US Pharmacopeia. United States Pharmacopeial Convention, Inc. 23, 1982–1984 (1994).
   Google Scholar
• ICH International Conference on Harmonisation. Draft guideline on validation of analytical procedures: definitions and terminology. Federal Register60, 11260 (1995).
   Google Scholar
• US FDA. Guideline for submitting samples and analytical data for methods validation. (1987).
   Google Scholar
• US FDA. Guidance for industry: Q2B validation of analytical procedures: methodology CDER/CBER. (1996).
   Google Scholar
• Green JM . A practical guide to analytical method validation. Anal. Chem. 68, 305–309 (1996).
   Web of Science ®Google Scholar
• Kutschera W . Progress in isotope analysis at ultra-trace level by AMS. Int. J. Mass Spec. (2005).
   Web of Science ®Google Scholar
• Scott EM . The fourth international radiocarbon intercomparison (FIRI). Radiocarbon45, 135–150 (2003).
   Web of Science ®Google Scholar
• Damon PE , DonahueDJ, GoreBHet al. Radiocarbon dating of the Shroud of Turin. Nature337, 611–615 (1989).
   Web of Science ®Google Scholar
• Turtletaub KW , FeltonJS, GledhillBLet al. Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA. Proc. Natl Acac. Sci. 87(14), 5288–5292 (1990).
   PubMed Web of Science ®Google Scholar
• Nelson DE , MortanRE, VogelJS, SouthonJR, HarringtonCR. New dates on northern Yukon artifacts: holocene, not pleistocene. Science232(4751), 749–751 (1986).
   PubMed Web of Science ®Google Scholar
• Vogel JS . Accelerator mass spectrometry for quantitative in vivo tracing. Biotechniques38, 25–29 (2005).
   Google Scholar
• Vogel JS , LoveA. Quantitating isotopic molecular labels with AMS. Methods Enzymol. 402, 402–422 (2005).
   PubMed Web of Science ®Google Scholar
• Turteltaub KW , VogelJS. Bioanalytical applications of accelerator mass spectrometry for pharmaceutical research. Curr. Pharm. Des. 6(10), 991–1007, (2000).
   PubMed Web of Science ®Google Scholar
• Lappin G , GarnerRC. Big physics, small doses: the use of AMS and PET in human microdosing of development drugs. Nat. Rev. Drug Discov. 2, 233–240 (2003).
   PubMed Web of Science ®Google Scholar
• Wilding IR , BellRA. Improved early clinical development through human microdosing studies. Drug Discov. Today10, 890 (2005).
   PubMed Web of Science ®Google Scholar
• Stuiver M , PolachH. Discussion: reporting of 14C Data. Radiocarbon19, 355–363 (1977).
   Web of Science ®Google Scholar
• Vogel JS . Rapid production of graphite without contamination for biomedical AMS. Radiocarbon34, 344–350 (1992).
   Web of Science ®Google Scholar
• Freeman SPHT , VogelJS. Biomedical accelerator mass spectrometry. Int. J. Mass Spec. Ion Process143, 247–256 (1995).
   Web of Science ®Google Scholar
• Liberman RG , TannenbaumSR, HugheyBJet al. An interface for direct analysis of 14C in nonvolatile samples by accelerator mass spectrometry. Anal. Chem. 76(2), 328–334 (2004).
   PubMed Web of Science ®Google Scholar
• Choi MH , SkierPL, WishnokJS, TannenbaumSR. Characterization of testosterone 11b-hydroxylation catalyzed by human liver microsomal cytochromes P450. Drug Metab. Dispos. 33, 714–718 (2005).
   PubMed Web of Science ®Google Scholar
• Guilderson TP , ReimerPJ, BrownTA. Geoscience: boon and bane of radiocarbon dating. Science307(5108), 362–364 (2005).
   PubMedGoogle Scholar
• Vogel JS , SouthonJR, NelaonDE, BrownTA. Performance of catalytically condensed carbon for use in accelerator mass spectrometry. Nucl. Inst. Meth. B5, 289–293 (1984).
   Google Scholar
• Buchholz BA , FreemanSPHT, HaackKW, VogelJS. Tips and traps in the 14C bio-AMS preparation laboratory. Nucl. Instrum. Methods Phys. Res. B172, 404–408 (2000).
   Web of Science ®Google Scholar
• Garner RC , BarkerJ, FlavellCet al. A validation study comparing accelerator MS and liquid scintillation counting for analysis of 14C-labelled drugs in plasma, urine and fecal extracts. J. Pharm. Biomed. Anal. 24, 197–209 (2000).
   PubMed Web of Science ®Google Scholar
• Polach HA . A sucrose standard for 14C dating. In: Proceedings of the 9th International Conference on Radiocarbon. Berger R, Suess H (Eds). UC Press, Berkeley/Los Angeles, CA, USA, 115–124 (1979).
   Google Scholar
• US FDA. Guidance for industry: safety testing of drug metabolites. CDER. (2006).
   Google Scholar
• Vogel JS , OgnibeneTJ, PalmbladM, ReimerP. Counting statistics and ion interval density in AMS. Radiocarbon46(3), 1103–1109 (2004).
   Web of Science ®Google Scholar
• Ognibene TJ , BenchG, VogelJS, PeasleeGF, MurovS. A high-throughput method for the conversion of CO2 obtained from biochemical samples to graphite in septa-sealed vials for quantification of 14C via accelerator mass spectrometry. Anal. Chem. 75(9), 2192–2196 (2003).
   PubMed Web of Science ®Google Scholar
• Milton GM , KramerSJ, MiltonJCD. Interlaboratory comparisons of C-14 measurements in milk and vegetation. Radiocarbon40, 299–311 (1998).
   Web of Science ®Google Scholar
• Shapiro SD , EndicottSK, ProvinceMA, PierceJA, CampbellEJ. Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of d-aspartate and nuclear weapons-related radiocarbon. J. Clin. Invest. 87(5), 1828–1834 (1991).
   PubMed Web of Science ®Google Scholar
• Spalding K , BhardwajRD, BuchholzB, DruidH, FrisénJ. Cell122, 133–143 (2005).
   PubMed Web of Science ®Google Scholar
• Bhardwaj RD , CurtisMA, SpaldingKLet al. Neocortical neurogenesis in humans is restricted to development. Proc. Natl Acad. Sci. USA103(33), 12564–125648 (2007).
   Web of Science ®Google Scholar
• Spalding K , ArnerE, WestermarkPOet al. Dynamics of fat cell turnover in humans. Nature453(7192), 169 (2008).
   Google Scholar
• Lin Y , DuekerSR, FollettJRet al. Quantitation of in vivo human folate metabolism. Am. J. Clin. Nutr. 80(3), 680–691 (2004).
   PubMed Web of Science ®Google Scholar
• Sandhu P , VogelJS, RoseMJet al. Evaluation of microdosing strategies for studies in preclinical drug development: demonstration of linear pharmacokinetics in dogs of a nucleoside analog over a 50-fold dose range. Drug Metab. Dispos. 32(11), 1254–1259 (2004).
   PubMed Web of Science ®Google Scholar
• Miyashita M , PriestleyJM, BuchholzBAet al. Attomole level protein sequencing by Edman degradation coupled with accelerator mass spectrometry. Proc. Natl Acad. Sci. USA98, 4403–4408 (2001).
   PubMed Web of Science ®Google Scholar
• Palmblad M , VogelJS. Quantitation of binding, recovery and desalting efficiency of peptides and proteins in solid phase extraction micropipette tips. J. Chromatogr. B814, 309–313 (2005).
   PubMed Web of Science ®Google Scholar
• Bennett JS , HillegondsDW, BuchholzBA, KwokESC, VogelJS, MortonTH. Accelerator mass spectrometry for assaying irreversible covalent modification of an enzyme by acetoacetic ester. Int. J. Mass Spec. 179–180, 185–193 (2000).
   Web of Science ®Google Scholar
• Ognibene TJ , BrownTA, KnezovichJP, RobertsML, SouthonJR, VogelJS. Ion-optics calculations of the LLNL AMS system for biochemical 14C measurements. Nucl. Instrum. Methods Phys. Res. B172(1–4), 47–51 (2000).
   Google Scholar
• Brown TA , RobertsML, SouthonJR. Ion-source modeling and improved performance of the CAMS high-intensity Cs-sputter ion source. Nucl. Instrum. Methods Phys. Res. B172 (2000).
   Web of Science ®Google Scholar
• Gorbarenko SA , KhusidTA, BasovIA, ObaT, SouthonJR, KoizumiI. Glacial Holocene environment of the southeastern Okhotsk Sea: evidence from geochemical and palaeontological data. Palaeogeogr. Palaeoclimatol. Palaeoecol. 177(3), 237–263(27) (2002).
   Web of Science ®Google Scholar

Websites

• GraphPad Software www.GraphPad.com
   Google Scholar
• QuantumSoft www.quansoft.com
   Google Scholar